Correlation Between Molecular Templates and Viridian Therapeutics
Can any of the company-specific risk be diversified away by investing in both Molecular Templates and Viridian Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Templates and Viridian Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Templates and Viridian Therapeutics, you can compare the effects of market volatilities on Molecular Templates and Viridian Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Templates with a short position of Viridian Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Templates and Viridian Therapeutics.
Diversification Opportunities for Molecular Templates and Viridian Therapeutics
-0.47 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Molecular and Viridian is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Templates and Viridian Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viridian Therapeutics and Molecular Templates is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Templates are associated (or correlated) with Viridian Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viridian Therapeutics has no effect on the direction of Molecular Templates i.e., Molecular Templates and Viridian Therapeutics go up and down completely randomly.
Pair Corralation between Molecular Templates and Viridian Therapeutics
Given the investment horizon of 90 days Molecular Templates is expected to generate 5.47 times more return on investment than Viridian Therapeutics. However, Molecular Templates is 5.47 times more volatile than Viridian Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Viridian Therapeutics is currently generating about -0.1 per unit of risk. If you would invest 50.00 in Molecular Templates on August 28, 2024 and sell it today you would lose (10.00) from holding Molecular Templates or give up 20.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Templates vs. Viridian Therapeutics
Performance |
| Timeline |
| Molecular Templates |
| Viridian Therapeutics |
Molecular Templates and Viridian Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Templates and Viridian Therapeutics
The main advantage of trading using opposite Molecular Templates and Viridian Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Templates position performs unexpectedly, Viridian Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viridian Therapeutics will offset losses from the drop in Viridian Therapeutics' long position.| Molecular Templates vs. Eliem Therapeutics | Molecular Templates vs. HCW Biologics | Molecular Templates vs. Scpharmaceuticals | Molecular Templates vs. Milestone Pharmaceuticals |
| Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |